
HBM Holdings Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from HBM Holdings Limited
Access all reports
HBM Holdings Limited is a China-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative antibody therapeutics. The company utilizes its proprietary antibody technology platforms to develop a pipeline of monoclonal antibodies targeting various diseases, including cancer and autoimmune disorders. HBM Holdings conducts research and clinical development independently and through strategic partnerships in both domestic and international markets. The company is headquartered in Shanghai, China, and its shares are listed on the HKEX.
Key slides for HBM Holdings Limited


H2 2024
HBM Holdings Limited


H1 2024
HBM Holdings Limited
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
2142
Country
🇭🇰 Hong Kong